| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |